LRI Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

LRI Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	+69	New	+$931	﹤0.01%	1376

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LRI Investments's RDY Position: Q2 2026 in Review

LRI Investments opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 69 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1376 among its holdings.

63 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

LRI Investments held 69 shares of Dr. Reddy's Laboratories worth $1K as of Q2 2026.
Dr. Reddy's Laboratories was a new LRI Investments position in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1376 holding.
63 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.